AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea
· Delayed Price · Currency is KRW
8,320.00
+20.00 (0.24%)
Apr 29, 2026, 3:30 PM KST
AptaBio Therapeutics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 233,175 | 251,341 | 171,234 | 201,805 | 237,483 |
| Market Cap Growth | 12.95% | 46.78% | -15.15% | -15.02% | - |
| Enterprise Value | 220,407 | 240,559 | 146,945 | 152,862 | - |
| Last Close Price | 8300.00 | 9350.00 | 6370.00 | 9050.00 | 10650.00 |
| Forward PE | - | 78.10 | 78.10 | 78.10 | 78.10 |
| PS Ratio | 63.06 | 67.97 | 50.95 | 623.11 | 4911.46 |
| PB Ratio | 4.94 | 5.33 | 3.16 | 3.29 | 4.54 |
| P/TBV Ratio | 5.05 | 5.45 | 3.16 | 3.32 | 4.54 |
| EV/Sales Ratio | 59.60 | 65.05 | 43.72 | 471.99 | - |
| Debt / Equity Ratio | 0.09 | 0.09 | 0.14 | 0.23 | 0.01 |
| Net Debt / Equity Ratio | -0.27 | -0.27 | -0.44 | -0.63 | -0.32 |
| Net Debt / EBITDA Ratio | 0.85 | 0.85 | 1.19 | 2.38 | 1.85 |
| Net Debt / FCF Ratio | 0.83 | 0.83 | 1.94 | 2.52 | 2.11 |
| Asset Turnover | 0.05 | 0.05 | 0.04 | 0.00 | - |
| Inventory Turnover | 5.75 | 5.75 | - | - | - |
| Quick Ratio | 1.84 | 1.84 | 1.67 | 65.10 | 16.58 |
| Current Ratio | 2.61 | 2.61 | 1.79 | 70.27 | 19.63 |
| Return on Equity (ROE) | -32.25% | -32.25% | -50.84% | -21.21% | - |
| Return on Assets (ROA) | -14.13% | -14.13% | -15.24% | -14.22% | - |
| Return on Capital Employed (ROCE) | -30.90% | -30.90% | -35.80% | -18.40% | -17.30% |
| Earnings Yield | -7.01% | -6.50% | -17.16% | -5.98% | -4.45% |
| FCF Yield | -6.58% | -6.10% | -7.24% | -7.65% | -3.32% |
| Buyback Yield / Dilution | -14.40% | -14.40% | -5.57% | -0.05% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.